Health Watch USA Logo Health Watch USA - Community Presentations
 

      

HW USA Presentations: 

View
PACCARB

Presentations
Professional Presentations & Comments  
  • Kevin Kavanagh, MD, MS:  Public comments given regarding the prevention of MRSA in the NICU along with the protection of healthcare workers and safety of infectious disease medical devices.   Nov. 15 & 16, 2018 CDC Healthcare Infection Control Practices Advisory Committee (HICPAC).  YouTube Video (5 mins): https://youtu.be/HOFCJxV2Rek 

  • Kevin Kavanagh, MD, MS, discusses healthcare worker and patient safety issues which are created by the United States Response to the drug resistant bacteria epidemic. Not setting firm standards and research integrity problems have prevented an effective response in may of our institutions. Nov. 2, 2018 Kentucky Nursing Association Conference -- Expanded slide set is used in this video.
    The Epidemic of Multi-Drug Resistance Organisms -- It is NOT the Nurses Fault!! 
    YouTube Video (12.36 mins):  https://youtu.be/k-_fXApc3lA     View Slides    Download Handout

  • Kevin Kavanagh, MD. comments regarding the National Quality Forum's (NQF) Renal Standing Committee’s non-approval of two metrics to measure dialysis center referral rates for kidney transplantation.  The final NQF CSAC recommendation was not to accept the Standing Committee’s recommendation and to refer the metrics back to the Standing Committee for reconsideration. Oct. 23, 2018.
    View YouTube Video: https://youtu.be/SCbpBMsUC8k 

  • Kevin Kavanagh, MD. comments regarding the National Quality Forum's metric #0496: Median Time from ED Arrival to ED Departure for Discharged ED Patients (The Lewin Group/CMS were sponsors). The National Quality Forum (NQF) Standing Committee recommended not to renew the quality measurement on Emergency Room wait times. This recommendation was upheld by the NQF Consensus Standards Approval Committee (CSAC). However, several members felt this quality measurement should be renewed. This abbreviated video contains some of their comments.

    Points argued for not approving the metric were that:
    1) The metric was not risk adjusted.
    2) There is not good evidence that it measures quality, just patient satisfaction.
    3) Other metrics measure ER wait times.

    The main points argued for approving the metric were that:
    1) Not having good evidence to show that the metric has validity in measuring quality is not applicable, since it would be very hard to ethically design a randomized control trial on ER Wait times.  Who would consent to be in such a study?
    2) That patient satisfaction should be given equal weight to quality in the assessment of metric validity.
    3) Risk adjustment for the acuity of hospital patients was not needed, since the hospital can staff according to the acuity profile of the patients they serve.
    4) The other metrics measuring ER wait times are being withdrawn.

    Final CSAC recommendation was to not renew the metric. View YouTube Video:  https://youtu.be/E1hJbgShM9k   

  • Kevin T. Kavanagh, MD, MS, comments on the need for greater focusing on the control of spread of Multi-Drug Resistant Organisms.  Antibiotic stewardship programs alone are not likely to reverse the epidemic and there is no certainty that new antibiotics can be developed.   The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria  (PACCARB) - Sept. 26, 2018.    YouTube Video (2 mins):  https://youtu.be/OnX-QH51JQ8     PACCARB Written Comments

  • Kevin Kavanagh, MD, MS, from Health Watch USA presents on Preventable Hospital Mortality. Preventable deaths are far too common. Little if any improvement has taken place since the 1999 Institute of Medicine's report which found between 44,000 and 98,000 preventable deaths. The figure may be even higher with multiple studies showing the rate to approximate 200,000 deaths per year. There have been far too many excuses and too little action. The Leapfrog Group estimates that over 33,000 lives would be saved if all hospitals functioned at a similar level to their group of highest performing hospitals. Anesthesia Patient Safety Foundation. Sept. 5, 2018.
    https://youtu.be/bndnpO-hr8Y       Download Handout

  • Kevin T. Kavanagh, MD, MS discusses the importance of forming standards for control of Resistant Organisms.  In addition he discusses problems created by research integrity and an overreliance on hand hygeine.   Presidential Advisory Committee on Combating Antibiotic Resistant Bacteria.   May 16, 2018.  YouTube Video https://youtu.be/ufOXcHitRp0    Download Text of Presentation

  • Multi-Drug Resistant Organism & Antibiotic Overutilization.  Kevin Kavanagh, MD from Health Watch USA discusses the causes and characteristics of the epidemic of multi-drug resistant organisms. Along with the cost to society if system-wide measures are not implemented to bring the epidemic under control. Edited version with pertinent PowerPoint slides. Jack Pattie Show - WVLK-AM March 28, 2018.  https://youtu.be/KDZUb5shG0k  

  • Multi-drug Resistant Bacteria - Incidence, Prevelance and Healthcare Transformation.  Dr. Kevin Kavanagh from Health Watch USA discusses the epidemic of multi-drug resistant organisms and their prevention, projected economic impact and patient mortality. In-depth discussion is given to C. Difficile, CRE and MRSA. Somerset Community College Public Presentation - Given March 19, 2018.   Download PDF of PowerPoint   YouTube Video:  https://youtu.be/FoBOjMqR7sU

  • Kevin T. Kavanagh, MD, MS, presents at The Leapfrog Group's Hospital Care Ratings Summit on Dec. 7, 2017. Topics discussed are preventable mortality, hospital accreditation surveys, antibiotic resistant infections (MRSA), medical devices, full disclosure, risk adjustment, value-based purchasing and research integrity.   YouTube Video: https://youtu.be/cmYJiKkC7HM    Download PowerPoint PDF  

  • Kevin Kavanagh, MD, MS provides a short comment on chlorhexidine research integrity, WHO recommendations for surgical antisepsis and FDA medical device approval.   Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) - Sept 14, 2017    
    https://youtu.be/W1XHZqqVuhs   Written Comment

  • Kavanagh KT.  Health Watch USA comments at the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria on MRSA tracking and prevention, along with the need for a better definition of an "outbreak", the over dependance on hand hygiene and the importance of knowing the patient's microbiome.  Sept. 13, 2017.   YouTube Video:   https://youtu.be/fLT8fOZrfzw

  • Kavanagh KT. Health Watch USA comments at the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria regarding the United States missing goals for reducing MRSA and other resistant pathogens along with the need for a mandatory publicly reported comprehensive surveillance system to track multi-drug resistant organisms.  Jan. 25, 2017.  YouTube Video:  https://youtu.be/hbdXX3a_OIY     Written Comments

  • Kavanagh KT. presents on preventable hospital mortality and how the context of the patient should not be used to lessen the severity of the event. In addition, the applicability of the foreign studies to predict the safety of the U.S. healthcare system is questioned.  Dec. 9, 2016.  YouTube Video:  https://youtu.be/HRlfhxB-cQY 

  • Kavanagh KT. Health Watch USA Comments at the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria.  "The committee needs to ensure that our healthcare institutions make the needed investments in prevention and patient safety, along with setting well-defined standards for screening, isolation, environmental cleaning, appropriate staffing and worker safety. "  Sept 19, 2016.  YouTube Video:  https://youtu.be/RGlpKY1L-S4     View Written Comment

  • Kavanagh KT. Health Watch USA Comments on the importance of preventing the transmission of resistant bacteria between patients. In addition, the importance of nursing, worker safety and carrier surveillance was stressed. Attention was also drawn to polymixin B in topical over-the-counter antibiotics as a possible cause of resistance to colistin. Presidential Advisory Council for Combating Antibiotic Resistant Bacteria. Jun. 21 2016. Washington DC. YouTube Video: https://youtu.be/t2LM9IuN7fQ   View Written Comment

  • Kavanagh KT. Health Watch USA Comments on the importance of preventing patient-to-patient transmission. Presidential Advisory Council for Combating Antibiotic Resistant Bacteria. Mar. 31 , 2016. Washington DC. YouTube Video: https://youtu.be/-IB1qF1qP48   

  • Kavanagh KT. Health Watch USA Comments on chlorhexidine, surveillance and public disclosure of conflicts of interest in the confrontation of the antibiotic bacterial resistance epidemic. Presidential Advisory Council for Combating Antibiotic Resistant Bacteria. Mar. 30, 2016. Washington DC. YouTube Video: https://youtu.be/iG1aQZftqb0  View Written Comment

  • Kavanagh KT. Health Watch USA Comments on research integrity, conflicts-of-interest, the need for firm standards, the tying of antibiotic stewardship to funds for antibiotic development and public reporting of antibiotic provider utilization data. Presidential Advisory Council for Combating Antibiotic Resistant Bacteria. Sep. 29, 2015. Washington DC. YouTube Video: https://youtu.be/b67J-X5c8gU   View Written Comment  

  • Kavanagh KT. MRSA Surveillance, Concerns Regarding Chlorhexidine and Bacterial Resistance. SFAR (Stakeholder' Forum in Antibiotic Resistance) Conference. Oct. 9, 2014. Philadelphia, PA.  YouTube Video https://youtu.be/MC7ztSASvuc    Download PDF of Slides  View Video of Presentation

  • Kavanagh KT. Prevention of MRSA infections using surveillance, isolation and decolonization. Bluegrass Healthcare Coalition. Lexington, KY. Mar. 18, 2014. YouTube Video: https://youtu.be/w6MVNjJZxd0  View Video of Presentation

HW USA Presentation Topics & Power Points

  • Nursing and Healthcare Policy.     View PowerPoint

  • The Certificate of Need - History and Current Status.     View PowerPoint

  • Healthcare Transparency, how to shop for health care and resources available to the consumer.     View PowerPoint

  • Hospital Acquired Conditions and Never Events.   The history and rational behind the current public policy.    (See Testimony Section)

  • Public Reporting of Hospital Acquired Infections.    (See Testimony Section)

  • Healthcare Transparency, Public Reporting and Adverse Events     View PowerPoint

 

 
MRSA Picture

The pictures on the right and left are photomicrographs of
Methicillin-resistant Staphylococcus Aureus (MRSA).